跳至主要内容
临床试验/NCT06122597
NCT06122597已完成不适用

A Clinical Trial to Evaluate the Efficacy of ConcenTrace to Buffer pH Levels Within the Body.

Trace Minerals2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年10月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Changes in urine pH levels. [Timeframe: Baseline to Week 12]

研究概览

简要总结

This virtual single-arm trial will last 12 weeks. Participants will take the drops daily and complete questionnaires at Baseline, Week 4, Week 8, and Week 12.

Urine pH measurements will be taken at Baseline, Week 4, Week 8, and Week 12 using pH test strips.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female. Aged 18+. Generally healthy - don't live with any uncontrolled disease. Willing to maintain their standard dietary pattern, activity level, and body weight for the duration of the study.

排除标准

  • Anyone with a pre-existing chronic condition that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
  • Anyone with known severe allergic reactions. Women who are pregnant, breastfeeding, or attempting to become pregnant. Anyone unwilling to follow the study protocol.

结局指标

主要结局

Changes in urine pH levels. [Timeframe: Baseline to Week 12]

时间窗: 12 weeks

Participants will use pH test strips to measure urine pH. Changes in urine pH will be evaluated.

次要结局

  • Change in score on the Metabolic Screening Questionnaire.(12 weeks)

研究者

发起方
Trace Minerals
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验